Integra Lifesciences Holdings (IART) EBT Margin (2009 - 2026)
Integra Lifesciences Holdings recorded quarterly EBT Margin of 0.61% in Q1 2026, down 162.03% quarter-over-quarter from 0.99% in Q4 2025, and up 723.0% year-over-year from 0.07% in Q1 2025.
Integra Lifesciences Holdings' EBT Margin history runs 18 years deep, the most recent figure standing at 0.61% for Q1 2026.
- In Q1 2026, EBT Margin rose 723.0% year-over-year to 0.61%; the TTM figure through Mar 2026 stood at 32.59% (down 2994.0% YoY), while the FY2025 annual figure was 34.46%, down 3333.0% from the prior year.
- EBT Margin came in at 0.61% for Q1 2026 at Integra Lifesciences Holdings, down from 0.99% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 16.13% in Q4 2022 to a low of 127.75% in Q2 2025.
- A 5-year average of 3.91% and a median of 1.0% in 2023 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin sank 12412 bps in 2025 and surged 723 bps in 2026, its largest moves.
- Integra Lifesciences Holdings' EBT Margin stood at 16.13% in 2022, then tumbled by 55 bps to 7.27% in 2023, then retreated by 30 bps to 5.09% in 2024, then plunged by 81 bps to 0.99% in 2025, then sank by 162 bps to 0.61% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 0.61%, 0.99%, and 1.7% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn | -0.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.61% |
| Dec 31, 2025 | 0.99% |
| Sep 30, 2025 | -1.70% |
| Jun 30, 2025 | -127.75% |
| Mar 31, 2025 | -7.85% |
| Dec 31, 2024 | 5.09% |
| Sep 30, 2024 | -5.35% |
| Jun 30, 2024 | -3.63% |
| Mar 31, 2024 | -1.42% |
| Dec 31, 2023 | 7.27% |
| Sep 30, 2023 | 4.87% |
| Jun 30, 2023 | 1.00% |
| Mar 31, 2023 | 7.82% |
| Dec 31, 2022 | 16.13% |
| Sep 30, 2022 | 15.26% |
| Jun 30, 2022 | 12.96% |
| Mar 31, 2022 | 10.44% |
| Dec 31, 2021 | 12.77% |
| Sep 30, 2021 | 13.13% |
| Jun 30, 2021 | 11.49% |
| Mar 31, 2021 | 18.68% |
| Dec 31, 2020 | 10.01% |
| Sep 30, 2020 | 11.21% |
| Jun 30, 2020 | 0.64% |
| Mar 31, 2020 | 3.23% |
| Dec 31, 2019 | 6.68% |
| Sep 30, 2019 | -7.26% |
| Jun 30, 2019 | 9.48% |
| Mar 31, 2019 | 6.90% |
| Dec 31, 2018 | 6.40% |
| Sep 30, 2018 | 3.01% |
| Jun 30, 2018 | 3.48% |
| Mar 31, 2018 | 2.56% |
| Dec 31, 2017 | -1.25% |
| Sep 30, 2017 | 1.16% |
| Jun 30, 2017 | 2.84% |
| Mar 31, 2017 | 1.83% |
| Dec 31, 2016 | 13.88% |
| Sep 30, 2016 | 9.98% |
| Jun 30, 2016 | 5.99% |
| Mar 31, 2016 | 6.33% |
| Dec 31, 2015 | 8.09% |
| Sep 30, 2015 | 2.37% |
| Jun 30, 2015 | 8.47% |
| Mar 31, 2015 | 8.78% |
| Dec 31, 2014 | 10.67% |
| Sep 30, 2014 | 5.55% |
| Jun 30, 2014 | 3.65% |
| Mar 31, 2014 | 2.17% |
| Dec 31, 2013 | 28.44% |
| Sep 30, 2013 | -17.20% |
| Jun 30, 2013 | 0.28% |
| Mar 31, 2013 | -4.02% |
| Dec 31, 2012 | 7.75% |
| Sep 30, 2012 | 6.79% |
| Jun 30, 2012 | 5.50% |
| Mar 31, 2012 | 4.89% |
| Dec 31, 2011 | 0.18% |
| Sep 30, 2011 | 5.58% |
| Jun 30, 2011 | 1.03% |
| Mar 31, 2011 | 8.19% |
| Dec 31, 2010 | 10.01% |
| Sep 30, 2010 | 11.93% |
| Jun 30, 2010 | 11.81% |
| Mar 31, 2010 | 11.18% |
| Dec 31, 2009 | -9.71% |
| Sep 30, 2009 | 10.53% |
| Jun 30, 2009 | 10.49% |